Skip to main content
$1.17 $0.11 (10.4%)

04:00 PM EDT on 09/26/23

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Current Price $1.17 Mkt Cap $260.9M
Open $1.05 P/E Ratio -1.71
Prev. Close $1.17 Div. (Yield) $0.00 (0.0%)
Daily Range $1.05 - $1.20 Volume 1,961,410
52-Wk Range $1.04 - $3.79 Avg. Daily Vol. 1,595,972

Caps

How do you think NASDAQ:LXRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

245 Outperform
43 Underperform
 

All-Star Players

30 Outperform
9 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:LXRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

asilverp (96.35)
Submitted September 18, 2014

insider buying....

Brosan (< 20)
Submitted January 28, 2011

With more less than 80c per share available in cash, LXRX will have a very hard time to keep their heads above water. The me-too compound, LX4211, seems to be stuck in the ground due to the lack of interest in the pharma community. Even it finds a… More

Recent Community Commentary

Read the most recent pitches from players about LXRX.

Recs

0
Member Avatar viddoshen589 (< 20) Submitted: 12/19/2019 5:58:41 PM : Outperform Start Price: $4.46 NASDAQ:LXRX Score: -106.66

is that $10

Recs

0
Member Avatar TMFBigFrog (88.40) Submitted: 1/27/2019 3:24:16 PM : Outperform Start Price: $4.56 NASDAQ:LXRX Score: -136.03

Potential for decent recovery if its type one diabetes medicine is approved.

Recs

0
Member Avatar manirg (< 20) Submitted: 8/28/2015 10:19:46 PM : Outperform Start Price: $11.94 NASDAQ:LXRX Score: -205.66

Fool Sean's pick & I like it too!!

Leaderboard

Find the members with the highest scoring picks in LXRX.

Score Leader

sglubis2

sglubis2 (94.30) Score: +397.34

The Score Leader is the player with the highest score across all their picks in LXRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
sglubis2 94.30 9/16/2009 Underperform 3M $19.60 -94.03% +303.31% +397.34 0 Comment
abedamri < 20 10/22/2009 Underperform 5Y $10.71 -89.08% +292.95% +382.03 0 Comment
Korodas 54.77 9/1/2010 Underperform NS $10.43 -88.78% +293.20% +381.99 0 Comment
longtermgrowth09 51.91 12/17/2009 Underperform 5Y $12.60 -90.71% +284.65% +375.36 0 Comment
stockjock11 49.88 1/20/2010 Underperform NS $16.94 -93.09% +275.03% +368.12 0 Comment
radmtom < 20 1/20/2010 Underperform 1Y $16.73 -93.01% +275.06% +368.07 0 Comment
foolstracker < 20 3/8/2010 Underperform 5Y $11.55 -89.87% +272.73% +362.60 0 Comment
str8nuts < 20 1/19/2010 Underperform 3W $13.65 -91.43% +270.14% +361.57 0 Comment
chuckyd5737 < 20 9/18/2006 Underperform 3M $26.39 -95.57% +242.60% +338.17 0 Comment
IdahoInvestor 99.72 12/19/2011 Underperform 5Y $7.14 -83.61% +249.34% +332.95 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for LXRX.